. Lemborexant: First Approval. Drugs. 2020 Mar;80(4):425-432. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

Therapeutics

  1. Dayvigo